BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 10, 2025
See today's BioWorld Asia
See today's BioWorld
See today's BioWorld MedTech
Home
» Clarity raises AU$203M to advance copper-based radiopharma pipeline
To read the full article
sign up for free
or
sign in
.
Clarity raises AU$203M to advance copper-based radiopharma pipeline
July 29, 2025
By
Tamra Sami
No Comments
Radiopharma Clarity Pharmaceuticals Ltd. raised AU$203 million (US$132.22 million) in an institutional placement on Australia’s Securities Exchange to advance its late-stage pipeline of copper-based radiopharmaceuticals.
BioWorld
BioWorld MedTech
BioWorld Asia
Financings
Cancer
Asia-Pacific